Article Details

Q2 2021 EPS Estimates for NGM Biopharmaceuticals, Inc. Lifted by Analyst (NASDAQ:NGM)

Retrieved on: 2021-08-02 05:15:00

Tags for this article:

Click the tags to see associated articles and topics

Q2 2021 EPS Estimates for NGM Biopharmaceuticals, Inc. Lifted by Analyst (NASDAQ:NGM). View article details on hiswai:

Excerpt

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) - Stock analysts at Piper Sandler upped their Q2 2021 EPS estimates for shares of NGM ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up